Defiance Daily Target 2X Long LLY ETF (LLYX)

Assets	$43.81M
Expense Ratio	1.49%
PE Ratio	n/a
Forward PE	n/a
Shares Out	1.31M
Dividend	$0.70 (1.92%)
Ex-Dividend Date	Dec 30, 2025
Payout Frequency	n/a
Payout Ratio	n/a

Volume	82,702
Open	35.86
Previous Close	35.97
Day's Range	35.60 - 36.95
52-Week Low	14.55
52-Week High	37.49
Beta	0.29
Holdings	12
Inception Date	Aug 7, 2024

About LLYX

Fund Home Page

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care stocks. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NYSE Arca
• Ticker Symbol: LLYX
• ETF Provider: Defiance

Top 10 Holdings

285.98% of assets

Name	Symbol	Weight
ELI LILLY & CO SWAP MS	n/a	72.99%
United States Treasury Bills 0%	B.0 11.19.26	42.23%
OTHER ASSETS AND LIABILITIES	n/a	32.84%
ELI LILLY & CO SWAP CS	n/a	23.40%
ELI LILLY & CO SWAP Cantor - L	n/a	23.18%
LLY SWAP NOMURA	n/a	23.01%
ELI LILLY AND COMPANY-SWAP-NBCB-L	n/a	22.24%
ELI LILLY & CO SWAP BMO	n/a	19.86%
ELI LILLY & CO SWAP MAREX	n/a	14.63%
First American Government Obligs X	FGXXX	11.59%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 30, 2025	$0.70417	Dec 31, 2025

Performance

LLYX had a total return of 57.00% in the past year, including dividends. Since the fund's inception, the average annual return has been 22.84%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Nov 14, 2026

Data Sources Report a data error